| Time after baseline | |
---|---|---|
Clinical | Current transplant listing status (active, suspended, removed, transplanted. If transplanted, the date and type of transplant will be recorded), comorbidities, current stage of kidney disease (pre-emptive, haemodialysis, peritoneal dialysis), date of death (if this has occurred), cause of death (if this has occurred), BMI | 12Â weeks |
Laboratory | Matchability, % calculated reaction frequency | 12Â weeks |
Resource use | Number of donors undergoing assessment | 12Â weeks |
Compliance with and acceptability of trial | Number of living donation letters posted to potential donors; number of home visits by intervention healthcare professional (HCP); content compliance (quantitative checklist for home visit content) | 4–8 weeks |
Patient reported | Renal and transplant knowledge (R3K-T [41]); social support (ISEL-12 [42, 43]); Patient Activation (PAM13 [26, 44]); health literacy (SILS [45, 46]); transplant preference; transplant beliefs [47]; experience talking to family and friends about kidney disease and living donation (binary response questions); quality of life (EQ-5D-5L [48]) | 4–8 weeks |